20
Ranbaxy Laboratories Limited Gurgaon In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Cefpodoxime proxetil, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2010-186 - Rev 01
This Chemical Type CEP, issued on August 08, 2013, remains in force until April 28, 2017, ensuring its reliability within the pharmaceutical industry.
Substance Number 2341 associated with this CEP further emphasizes